Outcomes following laryngectomy refusal after insufficient response to induction chemotherapy
- 26 November 2016
- journal article
- research article
- Published by Wiley in The Laryngoscope
- Vol. 127 (8) , 1791-1796
Abstract
Objective: To review patients who refused a total laryngectomy and were treated with radiotherapy (RT) after insufficient response to induction chemotherapy in a larynx preservation protocol for advanced‐stage cancer of the larynx and to compare their outcomes with good responders.Study Design: Retrospective cohort study.Methods: Eighty‐six patients treated with induction chemotherapy followed by RT were included in the analysis: 75 good responders and 11 insufficient responders who refused surgery. We compared overall survival (OS), disease‐free survival (DFS), and laryngo‐esophageal dysfunction‐free survival (LEDFS) of the cohort populations in univariate and multivariate analyses.Results: The median follow‐up was 44 months. The 2‐year and 5‐year survival rates were respectively 72.2% and 58.8% for OS, 62.8% and 49.4% for DFS, and 59.5% and 44.3% for LEDFS. No survival endpoint was significantly decreased among insufficient responders, contrary to what we expected. When we focused on patients with an initially fixed larynx, the recovery of larynx mobility after induction chemotherapy was not associated with OS (P = 0.6055), DFS (P = 0.459), or LEDFS (P = 0.7403).Conclusion: To the best of our knowledge, our study is the first patient treatment evaluation focused on subjects who refused a total laryngectomy after insufficient response to induction chemotherapy in a larynx preservation protocol for advanced‐stage cancer of the larynx. Surprisingly, these patients treated with RT in our cancer center did not experience decreased functional and oncologic outcomes compared to good responders. Further studies will explore the relevance of response criteria and their evaluation methods.Level of Evidence: 4. Laryngoscope, 127:1791–1796, 2017Keywords
This publication has 21 references indexed in Scilit:
- Taxane-Cisplatin-Fluorouracil As Induction Chemotherapy in Locally Advanced Head and Neck Cancers: An Individual Patient Data Meta-Analysis of the Meta-Analysis of Chemotherapy in Head and Neck Cancer GroupJournal of Clinical Oncology, 2013
- Larynx preservationCurrent Opinion in Oncology, 2012
- Laryngeal preservation with induction chemotherapy for hypopharyngeal squamous cell carcinoma: 10-year results of EORTC trial 24891Annals of Oncology, 2012
- Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): A comprehensive analysis by tumour siteRadiotherapy and Oncology, 2011
- Larynx Preservation Clinical Trial Design: Key Issues and Recommendations—A Consensus Panel SummaryInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- Randomized Trial of Induction Chemotherapy With Cisplatin and 5-Fluorouracil With or Without Docetaxel for Larynx PreservationJNCI: Journal of the National Cancer Institute, 2009
- Phase 3 Randomized Trial on Larynx Preservation Comparing Sequential vs Alternating Chemotherapy and RadiotherapyJNCI: Journal of the National Cancer Institute, 2009
- Concurrent Chemotherapy and Radiotherapy for Organ Preservation in Advanced Laryngeal CancerNew England Journal of Medicine, 2003
- Larynx Preservation in Pyriform Sinus Cancer: Preliminary Results of a European Organization for Research and Treatment of Cancer Phase III TrialJNCI: Journal of the National Cancer Institute, 1996
- Induction Chemotherapy plus Radiation Compared with Surgery plus Radiation in Patients with Advanced Laryngeal CancerNew England Journal of Medicine, 1991